Testimonies
We really appreciated working with the GIGA for the production of R&D-grade lentiviruses
“We really appreciated working with the GIGA for the production of R&D-grade lentiviruses. We’ve been pleased with the rapid and efficient communication provided. The advises and expertise provided by Emmanuel di Valentin was much appreciated and I highly speak of this collaboration with my co-worker and third parties for potential future collaborations. I hope you’ll be able to provide GMP-grade production capacities in the near-future.”
Nicolas Preyat, Project Manager, MaSTherCell sa
The platform is staffed with knowledgeable, skilled and helpful scientists who not only produce high quality viral vectors, but are also proficient at troubleshooting and adapting difficult experiments
"We have been collaborating with the Viral Vectors platform on several projects for many years and have been always very satisfied. The platform is staffed with knowledgeable, skilled and helpful scientists who not only produce high quality viral vectors, but are also proficient at troubleshooting and adapting difficult experiments. They also never hesitate to provide researchers with useful vectors from their extensive database, saving time and money for the users, and also provide useful advice for the design of new constructs".
Christophe Desmet, Welbio Principal Investigator, Laboratory of Cellular and Molecular Immunology, GIGA-I3
Dr. E. Di Valentin team at the Viral Vectors platform proved to be very efficient to provide us with the best up-to-date tools for our experiments and guided us for viral vector plasmid selection/design and for the choice of a particular strategy when needed.
"Ongoing projects conducted at the Metastasis Research Laboratory (MRL, GIGA-Cancer) are oriented toward the study of energy metabolism in cancer progression and metastasis. Dr. E. Di Valentin team at the Viral Vectors platform proved to be very efficient to provide us with the best up-to-date tools for our experiments and guided us for viral vector plasmid selection/design and for the choice of a particular strategy when needed".
Akeila Bellahcène, Metastasis Research Laboratory, GIGA-Cancer
